首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1343324篇
  免费   101073篇
  国内免费   4289篇
耳鼻咽喉   16865篇
儿科学   43870篇
妇产科学   36514篇
基础医学   198831篇
口腔科学   36165篇
临床医学   130523篇
内科学   259529篇
皮肤病学   26483篇
神经病学   112635篇
特种医学   48427篇
外国民族医学   366篇
外科学   185330篇
综合类   29084篇
现状与发展   1篇
一般理论   489篇
预防医学   115103篇
眼科学   29094篇
药学   99512篇
  6篇
中国医学   3171篇
肿瘤学   76688篇
  2021年   10988篇
  2019年   11745篇
  2018年   16431篇
  2017年   12377篇
  2016年   13333篇
  2015年   15287篇
  2014年   20985篇
  2013年   32308篇
  2012年   44555篇
  2011年   47220篇
  2010年   27264篇
  2009年   25115篇
  2008年   43043篇
  2007年   45428篇
  2006年   45501篇
  2005年   43977篇
  2004年   41912篇
  2003年   39812篇
  2002年   38586篇
  2001年   61128篇
  2000年   62763篇
  1999年   52523篇
  1998年   14687篇
  1997年   13351篇
  1996年   13204篇
  1995年   12540篇
  1994年   11707篇
  1993年   11003篇
  1992年   41787篇
  1991年   40958篇
  1990年   39651篇
  1989年   37521篇
  1988年   34752篇
  1987年   33883篇
  1986年   32331篇
  1985年   30803篇
  1984年   23168篇
  1983年   19703篇
  1982年   11848篇
  1979年   20894篇
  1978年   14884篇
  1977年   12119篇
  1976年   11957篇
  1975年   12181篇
  1974年   14872篇
  1973年   14576篇
  1972年   13434篇
  1971年   12481篇
  1970年   11528篇
  1969年   10467篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Abstract: We describe the use of restriction analysis on PCR-amplified DNA for detecting all B*27 subtypes except B*2710 and B*2711 (i.e. from B*2701 to B*2709). After detecting B*27 by Sty I, double digestions consisting of Sty I plus another informative enzyme led to subtype assignment. We used mismatched primers to create restriction sites when necessary. The method avoids group-specific amplifications and other laborious optimization procedures. It was successfully tested on a panel of well characterized cell lines covering different B*27 subtypes. Then, we studied a group of 57 ankylosing spondyiitis patients and 746 controls from the south of Spain. B*27 showed a very strong association with the disease (OR=211.27, P=\0˜7). B*2702 and B*2705 distribution in controls (20% and 77.1%, respectively) differed from previously reported data in the Spanish population. We unexpectedly found the B*2707 allele in our population (one control).  相似文献   
993.
994.
995.
996.
Resection of the adrenal glands precludes participation in many immunotherapy protocols for metastatic renal cell carcinoma. We performed radical nephrectomy with adrenalectomy and contralateral partial adrenalectomy, including adrenal vein ligation for a 4 cm. hilar metastasis without perioperative complications or local recurrence after 30 months. Adrenal function, measured by cosyntropin stimulation tests 6 weeks and 10 months postoperatively, was normal. Partial adrenalectomy with preservation of adrenal function is possible.  相似文献   
997.
998.
Irritability is often a problem for patients with Post-Traumatic Stress Disorder (PTSD). We describe two cases that illustrate the use of lithium in the treatment of veterans with PTSD who complained of serious problems with irritability or angry outbursts. These cases are discussed in the context of evidence that lithium may be useful in other patients with disorders of impulse control. The evidence linking disorders of anger and impulse control to a dysregulation in neurotransmitter regulation, particularly in serotonergic pathways, supports a psychopharmacologic approach to treatment. These findings should lead to further study of the role of lithium in the treatment of this symptom complex in patients with PTSD.  相似文献   
999.
Hormone replacement therapy is the optimal therapeutic choice for postmenopausal syndrome. While low doses of estrogens (0.3 mg/day of conjugated estrogens) can counteract neurovegetative menopausal symptoms, higher doses (0.625 mg/day of conjugated estrogens) are required to prevent bone loss in postmenopausal women. Experimental and clinical studies have shown that ipriflavone, a non-hormonal isoflavone derivative, is effective in the prevention and treatment of postmenopausal osteoporosis. The aim of the present investigation was to evaluate the efficacy and toler-ability of ipriflavone and very low doses of equine conjugated estrogens on bone loss in early postmenopausal women. Eighty-three healthy postmenopausal women (50.3±0.7 years) were enrolled for this 1-year multicenter study. All subjects were randomly allocated to receive: double placebo (n=24; group A), placebo plus conjugated equine estrogens 0.30 mg/day (n=31; group B) or conjugated equine estrogens 0.30 mg/day plus oral ipriflavone 200 mg tris in die at meals (n=28; group C), according to a double-masked design. Among women who completed the treatment period (valid completers), those of group A showed a progressive decrease in forearm bone density (FBD; measured by dual photon absorptiometry) that reached 1.7% after 12 months. The women in group B maintained their FBD in the first 6 months of treatment but, at the end of the study, showed a bone loss of 1.4% compared with basal values. By contrast, women in group C showed a significant increase in FBD after 1 year of treatment (+5.6%;p<0.01). Bothvalid completers andintention to treat analyses revealed a significant difference (p<0.05) between group A and group C over the study period. None of the treatments produced significant changes of biochemical markers of bone turnover, while hot flushes and other climacteric symptoms were significantly reduced after the sixth month of treatment in women receiving estrogens. Adverse events were generally mild, and did not differ among the groups. The results of this study suggest that low doses of estrogens combined with ipriflavone could represent a new therapeutic approach to the treatment of the postmenopausal syndrome.  相似文献   
1000.
The discovery of an inducible isoform of cyclooxygenase (COX-2) requires a refinement of the theory that inhibition of cyclooxygenase activity is responsible for both therapeutic and side-effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Pharmacological results with developmental compounds suggest that COX-2 is the relevant target for the therapeutic (i.e. anti-inflammatory) effects of NSAIDs, whereas gastric and renal side-effects are related to inhibition of constitutive COX-1. However a role of COX-1 in inflammation cannot be excluded. Furthermore, more research effort is needed to investigate the functional relevance of COX-2 in normal tissue.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号